Compare · NIVF vs PGNY
NIVF vs PGNY
Side-by-side comparison of NewGenIvf Group Limited (NIVF) and Progyny Inc. (PGNY): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both NIVF and PGNY operate in Misc Health and Biotechnology Services (Health Care), so they compete in similar markets.
- PGNY is the larger of the two at $2.02B, about 7233.3x NIVF ($279,723).
- Over the past year, NIVF is down 99.9% and PGNY is up 15.1% - PGNY leads by 115.0 points.
- PGNY has been more active in the news (25 items in the past 4 weeks vs 16 for NIVF).
- PGNY has more recent analyst coverage (25 ratings vs 0 for NIVF).
PerformanceNIVF-99.92%PGNY+15.08%
2025-06-10+0.00%2026-06-09
- Company
- NewGenIvf Group Limited
- Progyny Inc.
- Price
- $0.48-14.13%
- $25.80-0.58%
- Market cap
- $279,723
- $2.02B
- 1M return
- -60.25%
- +8.81%
- 1Y return
- -99.92%
- +15.08%
- Industry
- Misc Health and Biotechnology Services
- Misc Health and Biotechnology Services
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2019
- News (4w)
- 16
- 25
- Recent ratings
- 0
- 25
PGNY
Progyny Inc.
Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides surrogacy and adoption reimbursement programs for employers. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.
Latest NIVF
- Large owner Hrt Financial Lp sold $50,722 worth of shares (64,945 units at $0.78), decreasing direct ownership by 78% to 18,134 units (SEC Form 4)
- Director Siu Wing Fung Alfred exercised 56,851 units of Class B Ordinary Shares at a strike of $0.00, increasing direct ownership by 189,503% to 56,881 units (SEC Form 4)
- Director Fong Hei Yue Tina exercised 56,851 units of Class B Ordinary Shares at a strike of $0.00, increasing direct ownership by 145,772% to 56,890 units (SEC Form 4)
- Large owner Hrt Financial Lp bought $32,000 worth of shares (34,756 units at $0.92), increasing direct ownership by 72% to 83,079 units (SEC Form 4)
- New insider Hrt Financial Lp claimed ownership of 71,341 shares (SEC Form 3)
- K25.ai Secures US$6 Million Strategic Investment from Nasdaq-Listed NewGen at US$100 Million Valuation; Co-Founders to Join Board and Lead Digital Asset Treasury Strategy
- SEC Form 6-K filed by NewGenIvf Group Limited
- NewGen Doubles Down on K25.ai with Additional US$4 Million Stake and Adopts Digital Asset Treasury Strategy
- Large owner Hrt Financial Lp sold $68,254 worth of shares (85,317 units at $0.80), decreasing direct ownership by 61% to 54,561 units (SEC Form 4)
- SEC Form 6-K filed by NewGenIvf Group Limited
Latest PGNY
- Amendment: SEC Form SCHEDULE 13G/A filed by Progyny Inc.
- CHIEF FINANCIAL OFFICER Livingston Mark S. covered exercise/tax liability with 1,421 shares and sold $64,184 worth of shares (2,517 units at $25.50) as part of a pre-agreed trading plan, decreasing direct ownership by 5% to 74,688 units (SEC Form 4) (tax withholding)
- EVP, GC Swartz Allison covered exercise/tax liability with 1,015 shares and sold $45,022 worth of shares (1,798 units at $25.04) as part of a pre-agreed trading plan, decreasing direct ownership by 3% to 82,378 units (SEC Form 4) (for withholding tax)
- CHIEF EXECUTIVE OFFICER Anevski Peter covered exercise/tax liability with 5,361 shares, decreasing direct ownership by 0.66% to 811,472 units (SEC Form 4) to satisfy tax liability
- CHIEF FINANCIAL OFFICER Livingston Mark S. covered exercise/tax liability with 158 shares and sold $7,310 worth of shares (279 units at $26.20) as part of a pre-agreed trading plan, decreasing direct ownership by 0.55% to 78,626 units (SEC Form 4) (withholding tax)
- Director Scott Cheryl exercised 14,667 shares at a strike of $13.00, covered exercise/tax liability with 7,228 shares and sold $196,278 worth of shares (7,439 units at $26.39) (SEC Form 4)
- Chief Product Officer Clapp Geoffrey sold $39,137 worth of shares (1,530 units at $25.58), exercised 12,909 shares at a strike of $20.91 and covered exercise/tax liability with 11,379 shares (SEC Form 4) (for tax liability)
- EVP, GC Swartz Allison covered exercise/tax liability with 1,352 shares and sold $61,053 worth of shares (2,398 units at $25.46) as part of a pre-agreed trading plan, decreasing direct ownership by 4% to 85,191 units (SEC Form 4) to cover withholding tax
- Director Gordon Kevin K sold $137,445 worth of shares (5,500 units at $24.99), disposed of 2,526 shares and acquired 2,526 shares, decreasing direct ownership by 54% to 6,792 units (SEC Form 4)
- New Progyny Study Shows Growing Demand for Human Guidance in an Increasingly Digital Healthcare System